Clinical trial · Interventional
ACT-Based Nursing Intervention for Ovarian Cancer Patients: A Pilot Study
Development of ACT (Acceptance and Commitment Therapy)-Based Nurse-led Intervention for Ovarian Cancer Patients
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the feasiblity and effectiveness of an Acceptance and Commitment Therapy (ACT)-based nursing intervention aimed at managing psychological flexibility, distress, anxiety, depression, fear of cancer recurrence/progression, quality of life, and symptoms. Patients will participate in a single online session with a nurse, followed by a daily self-monitoring survey online for one week. Data will be collected at baseline (prior to the ACT session), on day 8 (after one week of self-monitoring), and at 5 weeks. Primary outcome is psychological flexibility.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Ovarian Neoplasm ; Psychological Distress | Ovarian Neoplasm | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ACT-based nursing intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- A
- description
- Experimental group with application of ACT-based nursing intervention
- interventionNames
- Other: ACT-based nursing intervention
Primary outcomes (1)
- measure
- Change from baseline psychological distress on the last day of self-monitoring (Day 8)
- timeFrame
- Psychological distress will be assessed at baseline and on the last day of self-monitoring (Day 8).
- description
- Psychological distress measured by Distress Thermometer.
Secondary outcomes (6)
- measure
- Change from baseline depression
- timeFrame
- within 3 weeks after the last day of self-monitoring (window: 7 days)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 19 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * adult (19 ≤ age ≤ 75). * ovarian cancer patients with FIGO stage 2-3. * Those who have completed first-line chemotherapy for ovarian cancer (excluding maintenance therapy) within the past 2 years. Exclusion Criteria: * Patients with cognitive problems such as dementia or psychiatric problems such as major depression or generalized anxiety, or who are actively receiving treatment for any of these conditions. * Patients with history of cancer recurrence.
References
Publications (0)
Data not yet available